Thursday, October 12, 2023 11:09:43 AM
Form 144 - Report of proposed sale of securities
October 12 2023 - 10:17AM
Edgar (US Regulatory)
Alert
Share On Facebook
="/Images/box-unchecked.jpg" alt="Checkbox not checked">
37650 10/24/2022 Compensation insiders most not have any faith in DNA stock value.
* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
144: Securities Sold During The Past 3 Months
Name and Address of Seller Title of Securities Sold Date of Sale Amount of Securities Sold Gross Proceeds
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 07/12/2023 37650 78776.11
Bartholomew Canton
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 07/13/2023 37650 83782.15
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 07/19/2023 37650 93103.44
Bartholomew Canton
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 07/20/2023 37650 85999.56
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 07/26/2023 37650 89622.33
Bartholomew Canton
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 07/27/2023 37650 88645.18
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/02/2023 37650 77892.67
Bartholomew Canton
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/03/2023 37650 76904.16
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/09/2023 37650 76697.51
Bartholomew Canton
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/10/2023 37650 66491.76
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/16/2023 37650 63189.95
Bartholomew Canton
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/17/2023 37650 61694.31
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/23/2023 37650 65600.06
Bartholomew Canton
27 Drydock Avenue, 8th Floor
Boston ? MA ? 02210 Class A 08/24/2023 37650 64025.25
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 08/30/2023 37650 83426.08
Bartholomew Canton
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 08/31/2023 37650 86356.01
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 09/06/2023 37650 83882.34
Bartholomew Canton
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 09/07/2023 37650 80239.80
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 09/13/2023 37650 76906.43
Bartholomew Canton
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 09/14/2023 37650 75136.13
Reshma Shetty
27 Drydock Avenue
8th Floor
Boston ? MA ? 02210 Class A 09/20/2023 37650 69221.51
Bartholomew Canton
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 09/21/2023 37650 66470.08
Reshma Shetty
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 09/27/2023 37650 68898.31
Bartholomew Canton
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 09/28/2023 37650 65869.77
Reshma Shetty
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 10/04/2023 37650 60836.57
Reshma Shetty
27 Drydock Avenue 8th Floor
Boston ? MA ? 02210 Class A 10/11/2023 37650 66126.30
Bartholomew Canton
27 Drydock Ave
8th Floor
Boston ? MA ? 02210 Class A 10/05/2023 37650 6279
Recent DNA News
- Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation • PR Newswire (US) • 05/02/2024 11:00:00 AM
- Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors • PR Newswire (US) • 04/29/2024 08:01:00 PM
- Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products • PR Newswire (US) • 04/16/2024 11:02:00 AM
- Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service" • PR Newswire (US) • 04/11/2024 11:01:00 AM
- Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets • PR Newswire (US) • 04/11/2024 11:01:00 AM
- Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain • PR Newswire (US) • 04/10/2024 11:02:00 AM
- Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks • PR Newswire (US) • 04/10/2024 11:01:00 AM
- IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service • PR Newswire (US) • 04/08/2024 11:00:00 AM
- Ginkgo Bioworks to Host 5th Annual Ferment Conference • PR Newswire (US) • 04/04/2024 11:01:00 AM
- Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing • PR Newswire (US) • 04/03/2024 11:02:00 AM
- Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs • PR Newswire (US) • 04/02/2024 11:02:00 AM
- Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments • PR Newswire (US) • 03/28/2024 11:02:00 AM
- AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production • PR Newswire (US) • 03/27/2024 11:02:00 AM
- Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins • PR Newswire (US) • 03/26/2024 11:02:00 AM
- CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago • PR Newswire (US) • 03/12/2024 11:01:00 AM
- CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago • GlobeNewswire Inc. • 03/12/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 02:55:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:58:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:56:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 03:27:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 03:09:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:08:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 03:04:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 05:42:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 12:43:14 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM